Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
24 May 2020	Submitted	Original manuscript
24 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
24 May 2020	Editorially accepted
3 Jun 2020	Article published	10.1186/s13063-020-04453-5

Back to article page